Engineered protein prevents AIDS virus from entering cells
April 1st, 2011 - 2:49 pm ICT by ANIWashington, April 1 (ANI): Scientists have engineered a new protein that prevents AIDS virus from entering cells.
The protein fragment is based on a naturally occurring protein called RANTES, which is part of the body’s immune system.
RANTES naturally defends the body against HIV/AIDS, but cannot be used as a drug or drug candidate because it has several other biological effects, which could cause harmful inflammation.
After examining the precise molecular structure of the RANTES protein, the researchers discovered that only a small fragment of the RANTES protein is actually responsible for blocking HIV entry into cells.
From there, they dissected the desired section of the RANTES protein and worked to stabilize it without compromising its protective effects.
After several sequential steps of molecular refinement and some virtual modeling, the researchers created a peptide with very high potency against HIV, with possible benefits for treating inflammatory diseases such as arthritis and lupus, as well as the prevention of transplant rejection.
“This is science fiction made reality. These researchers took a protein apart and removed the portion that causes harm, then stabilized and modified the section that has a therapeutic effect,” said Gerald Weissmann, Editor-in-Chief of The FASEB Journal.
“Not only is this good news for people with AIDS, but also it’s good news for all of us as this research paves the way for similar work for many, many other illnesses,” he added.
The study is published in the April 2011 issue of The FASEB Journal. (ANI)
- Discovery suggests new way to prevent HIV from infecting human cells - Dec 23, 2010
- Promising new HIV drug keeps virus out of cells - Aug 19, 2010
- Scientists discover protein that reduces blood pressure - Oct 01, 2010
- New 'Nanobody' agents help identify patients who will benefit from breast cancer drugs - Apr 12, 2011
- Honey can work as antibiotic - Jul 01, 2010
- Study offers potential new targets for novel anti-HIV drugs - Mar 26, 2011
- Why some people with HIV develop AIDS and others don't - May 06, 2010
- Here's what ups amyloid beta production in Alzheimer's patients' brains - Sep 04, 2009
- New antibodies to combat Alzheimer's - Dec 12, 2011
- 'Survival protein' can help treat neuro-disorders - May 24, 2011
- Insight into structure of HIV protein may help design drugs - Jun 10, 2010
- Gene transfer could help jump-start ailing heart - Oct 06, 2009
- 1 drug, many targets may be the future of healing! - Apr 29, 2011
- Influenza's Achilles heel discovered - Oct 30, 2009
- HIV drugs can also kill malaria parasites: Study - May 03, 2011
Tags: aids virus, biological effects, drug candidate, faseb journal, gerald weissmann, high potency, hiv aids, hiv entry, immune system, inflammation, inflammatory diseases, lupus, peptide, precise molecular structure, protein fragment, rantes, refinement, sequential steps, therapeutic effect, transplant rejection